Titan Pharmaceuticals, Inc. Shareholders' Equity
Titan Pharmaceuticals, Inc. had Shareholders' Equity of $2.79 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-08-14
- 2025-06-30: Stockholders' Equity Attributable to Parent $2.79M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $1.88M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $2.44M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $3.23M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | $2.79M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $2.44M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $3.23M 10-Q · filed 2025-01-03 |
| 2024-06-30 | $3.99M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $6.09M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $6.64M 10-Q · filed 2025-08-14 |
| 2023-09-30 | $8.13M 10-Q · filed 2025-01-03 |
| 2023-06-30 | -$1.03M 10-Q · filed 2025-01-03 |
| 2023-03-31 | -$312.00K 10-Q · filed 2025-01-03 |
| 2022-12-31 | $1.36M 10-K · filed 2025-03-20 |
| 2022-09-30 | $3.55M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $5.67M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $7.88M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $5.14M 10-K · filed 2024-04-01 |
| 2021-09-30 | $7.50M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $8.75M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $9.98M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $3.53M 10-K · filed 2023-03-31 |
| 2020-09-30 | -$897.00K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $1.56M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $5.28M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $1.43M 10-K · filed 2022-03-25 |
| 2019-09-30 | -$2.66M 10-Q · filed 2020-11-16 |
| 2019-06-30 | -$571.00K 10-Q · filed 2020-11-16 |
| 2019-03-31 | $3.06M 10-Q · filed 2020-11-16 |
| 2018-12-31 | $6.83M 10-K · filed 2021-03-31 |
| 2018-09-30 | $5.49M 10-Q · filed 2019-11-14 |
| 2018-06-30 | -$1.31M 10-Q · filed 2019-11-14 |
| 2018-03-31 | -$846.00K 10-Q · filed 2019-11-14 |
| 2017-12-31 | $857.00K 10-K · filed 2020-03-30 |
| 2017-09-30 | $4.04M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $7.54M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $10.61M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $13.19M 10-K/A · filed 2019-04-02 |
| 2016-09-30 | $15.26M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $17.68M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $5.48M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $6.99M 10-K/A · filed 2019-04-02 |
| 2015-09-30 | $8.92M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $1.99M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $4.19M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $8.61M 10-K · filed 2018-04-02 |
| 2014-09-30 | $4.25M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $3.46M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $4.28M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $5.76M 10-K · filed 2017-03-16 |
| 2013-09-30 | $1.02M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.15M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$3.05M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$23.13M 10-K · filed 2016-03-15 |
| 2012-09-30 | -$27.13M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$23.00M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$23.69M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$20.08M 10-K · filed 2015-03-31 |
| 2011-09-30 | -$17.55M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$16.98M 10-Q/A · filed 2011-08-17 |
| 2010-12-31 | -$6.05M 10-K · filed 2014-03-31 |
| 2009-12-31 | -$1.45M 10-K · filed 2013-03-18 |
| 2008-12-31 | $1.79M 10-K · filed 2012-03-15 |